Evidence map›Paper›PMID 25390032›Full record

ArticlePloS one2014

Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.

Adrian Flierl, Luís M A Oliveira, Lisandro J Falomir-Lockhart, Sally K Mak, Jayne Hesley, Frank Soldner, Donna J Arndt-Jovin, Rudolf Jaenisch, J William Langston, Thomas M Jovin and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Neuronal-type-specific epigenome editing to decreaseMolecular therapy. Nucleic acids · 2024
    Article
  8. Article
  9. Article
  10. Nuclease-dead S.bioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases.International journal of molecular sciences · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Adrian FlierlThe Parkinson's Institute, Sunnyvale, California, United States of America.
Luís M A OliveiraMax Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Lisandro J Falomir-LockhartMax Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Sally K MakThe Parkinson's Institute, Sunnyvale, California, United States of America.
Jayne HesleyMolecular Devices, LLC, Sunnyvale, California, United States of America.
Frank SoldnerThe Whitehead Institute and Department of Biology, MIT, Cambridge, Massachusetts, United States of America.
Donna J Arndt-JovinMax Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Rudolf JaenischThe Whitehead Institute and Department of Biology, MIT, Cambridge, Massachusetts, United States of America.
J William LangstonThe Parkinson's Institute, Sunnyvale, California, United States of America.
Thomas M JovinMax Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Birgitt SchüleThe Parkinson's Institute, Sunnyvale, California, United States of America.
Max Planck Institute for Biophysical Chemistry · DEParkinson's Institute and Clinical Center · USWhitehead Institute for Biomedical Research · USMolecular Devices

Funding

Transcriptional condensates, epigenetic editing and Rett SyndromeR01MH104610 · NIMH · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, YOUNG, RICHARD · 2014 to 2023
$7.4M
An iPSC based platform for functionally assessing genetic and environmental riskR01NS088538 · NINDS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF, MYERS, RICHARD H · 2014 to 2018
$5.0M
Programming and Reprogramming Human CellsR01CA084198 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI JAENISCH, RUDOLF · 2009 to 2013
$4.3M
NCI NIH HHS R01 CA084198NIMH NIH HHS R01 MH104610NINDS NIH HHS R01 NS088538
6 · The paper itself

Abstract

Parkinson disease (PD) is a multi-factorial neurodegenerative disorder with loss of dopaminergic neurons in the substantia nigra and characteristic intracellular inclusions, called Lewy bodies. Genetic predisposition, such as point mutations and copy number variants of the SNCA gene locus can cause very similar PD-like neurodegeneration. The impact of altered α-synuclein protein expression on integrity and developmental potential of neuronal stem cells is largely unexplored, but may have wide ranging implications for PD manifestation and disease progression. Here, we investigated if induced pluripotent stem cell-derived neuronal precursor cells (NPCs) from a patient with Parkinson's disease carrying a genomic triplication of the SNCA gene (SNCA-Tri). Our goal was to determine if these cells these neuronal precursor cells already display pathological changes and impaired cellular function that would likely predispose them when differentiated to neurodegeneration. To achieve this aim, we assessed viability and cellular physiology in human SNCA-Tri NPCs both under normal and environmentally stressed conditions to model in vitro gene-environment interactions which may play a role in the initiation and progression of PD. Human SNCA-Tri NPCs displayed overall normal cellular and mitochondrial morphology, but showed substantial changes in growth, viability, cellular energy metabolism and stress resistance especially when challenged by starvation or toxicant challenge. Knockdown of α-synuclein in the SNCA-Tri NPCs by stably expressed short hairpin RNA (shRNA) resulted in reversal of the observed phenotypic changes. These data show for the first time that genetic alterations such as the SNCA gene triplication set the stage for decreased developmental fitness, accelerated aging, and increased neuronal cell loss. The observation of this "stem cell pathology" could have a great impact on both quality and quantity of neuronal networks and could provide a powerful new tool for development of neuroprotective strategies for PD.

Indexed as

Gene Duplicationalpha-SynucleinApoptosisCell DifferentiationCells, CulturedCell SurvivalCellular SenescenceCulture MediaEnergy MetabolismFemaleGene Expression RegulationGlucoseHumansHydrogen PeroxideInduced Pluripotent Stem CellsMalealpha-SynucleinCulture MediaGlucoseHydrogen PeroxideRNA, Small InterferingSNCA protein, humanStaurosporine

Identifiers

PMID25390032
PMCPMC4229205
OpenAlexW2068515212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.